» Articles » PMID: 17029286

Neural Stem Cells for the Treatment of Disorders of the Enteric Nervous System: Strategies and Challenges

Overview
Journal Dev Dyn
Publisher Wiley
Date 2006 Oct 10
PMID 17029286
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The main goal of this review is to summarize the status of the research in the field of stem cells transplantation, as it is applicable to the treatment of gastrointestinal motility. This field of research has advanced tremendously in the past 10 years, and recent data produced in our laboratories as well as others is contributing to the excitement on the use of neural stem cells (NSC) as a valuable therapeutic approach for disorders of the enteric nervous system characterized by a loss of critical neuronal subpopulations. There are several sources of NSC, and here we describe therapeutic strategies for NSC transplantation in the gut. These include using NSC as a relatively nonspecific cellular replacement strategy in conditions where large populations of neurons or their subsets are missing or destroyed. As with many other recent "breakthroughs" stem cell therapy may eventually prove to be overrated. However, at the present time, it does appear to provide the hope for a true cure for many currently intractable diseases of both the central and the peripheral nervous system. Certainly more extensive research is needed in this field. We hope that our review will encourage new investigators in entering this field of research ad contribute to our knowledge of the potentials of NSC and other cells for the treatment of gastrointestinal dysmotility.

Citing Articles

Enhancement of enteric neural stem cell neurogenesis by glial cell-derived neurotrophic factor in experimental Hirschsprung's disease.

Fujiwara N, Lee D, Li B, Pierro A, Yamataka A Pediatr Surg Int. 2024; 40(1):274.

PMID: 39460767 DOI: 10.1007/s00383-024-05861-3.


Hypoxia-Inducible Factor 1α Stabilization Restores Epigenetic Control of Nitric Oxide Synthase 1 Expression and Reverses Gastroparesis in Female Diabetic Mice.

Gao F, Hayashi Y, Saravanaperumal S, Gajdos G, Syed S, Bhagwate A Gastroenterology. 2023; 165(6):1458-1474.

PMID: 37597632 PMC: 10840755. DOI: 10.1053/j.gastro.2023.08.009.


Programmed cell death in stem cell-based therapy: Mechanisms and clinical applications.

Hu X, Zhang Q, Zhou R, Wu Y, Li Z, Zhang D World J Stem Cells. 2021; 13(5):386-415.

PMID: 34136072 PMC: 8176847. DOI: 10.4252/wjsc.v13.i5.386.


Resveratrol promotes the survival and neuronal differentiation of hypoxia-conditioned neuronal progenitor cells in rats with cerebral ischemia.

Yao Y, Zhou R, Bai R, Wang J, Tu M, Shi J Front Med. 2020; 15(3):472-485.

PMID: 33263836 DOI: 10.1007/s11684-021-0832-y.


Exposure to GDNF Enhances the Ability of Enteric Neural Progenitors to Generate an Enteric Nervous System.

McKeown S, Mohsenipour M, Bergner A, Young H, Stamp L Stem Cell Reports. 2017; 8(2):476-488.

PMID: 28089669 PMC: 5312076. DOI: 10.1016/j.stemcr.2016.12.013.